• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 14, 2005

View Archived Issues

Caveolin-1 binding domain of HIV-1 gp41 as an epitope for a vaccine candidate/News in Context

Read More

sanofi-aventis reaffirms commitment to VEGF Trap alliance with Regeneron

Read More

Remune completes phase II studies in Italy, Spain

Read More

Safinamide shows promise in restless legs syndrome pilot study

Read More

Sunesis extends Cathepsin S inhibitor collaboration with Johnson & Johnson

Read More

TaiGen enters strategic alliance with P&G for antibiotic compound

Read More

Campral available in U.S.

Read More

BioAxone cleared to commence U.S. clinical development of Cethrin

Read More

Manufacturing milestone towards IND filing for PSA-PAH1

Read More

Enrollment begins in phase III Alzheimer's study of Flurizan

Read More

SPA for Avanir's phase III study of Neurodex

Read More

Positive phase IIa data for subset of patients treated with Miraxion

Read More

Positive data for oral Rambazole in psoriasis

Read More

Phase IIa data show utility of oral azoline in superficial fungal infections

Read More

FAS-20013 to enter clinical trials in TB and multidrug-resistant TB this year

Read More

Phase III study of long-acting injectable paliperidone palmitate in schizophrenia

Read More

KRX-101 phase II/III program recommended to continue to phase III

Read More

PEGylated integrin alpha4beta1 inhibitor with improved pharmacokinetic and pharmacodynamic profiles

Read More

Dextofisopam reported effective and well tolerated in IBS

Read More

PET scans provide new data on the effects of EMD-281014 in brain

Read More

Two clinical studies support the use of recombinant human albumin as an alternative to HSA

Read More

Phase III data on the effects of peginterferon alfa-2b plus ribavirin in HIV-HCV coinfection

Read More

MRS-2365: a novel, potent and selective P2Y1 receptor agonist

Read More

Nicotinic acetylcholine alpha7 receptor agonist with potential for the treatment of schizophrenia

Read More

PDE4 inhibitors described by Merck Frosst

Read More

sanofi-aventis patent claims CCR2B receptor antagonists

Read More

A series of quinolones for the treatment of CNS disorders

Read More

Scientists at 3-Dimensional Pharmaceuticals present novel protein tyrosine kinase inhibitors

Read More

Pfizer researchers report discovery of compounds with utility in diagnosis of CNS disorders

Read More

A series of antibacterial compounds described in patent literature

Read More

AstraZeneca prepares and tests vanilloid receptor antagonists

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 13, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for June 13, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 10, 2025
  • Enflonsia

    Merck wins FDA approval in pediatric RSV and steps into CDC uncertainty

    BioWorld
    With the U.S. FDA’s approval of Enflonsia (clesrovimab) to prevent respiratory syncytial virus (RSV) infection lower respiratory tract disease in newborns and...
  • Cancer cell in the cross-hairs

    Pan-cancer proteome atlas reveals new biomarkers and targets

    BioWorld Science
    An international group of scientists has completed the first draft of The Pan-Cancer Proteome Atlas (TPCPA). The project is based on mass spectrometry of 22...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe